Long

CWBR CohBar retracement completed ! Buy opportunity?

728
CWBR CohBar is developing mitochondria based therapeutics for the treatment of age-related diseases.
So it`s an anti-aging listed companies.
They released positive topline results from an early stage study into CB4211, a drug under development for the treatment of nonalcoholic steatohepatitis, but after a 70% increase, the stock went even lower than before the pump.

WBB Securities upgraded CohBar, Inc. stock to Buy from Speculative Buy with a price target of $5.

On 4/23/2021 Maxim Group brokerage Initiated Coverage with a Buy rating and a price target of $3.00

The Market Cap is only 72.138M

I see a lot of potential in this stock! Do you?

면책사항

해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.